Home » GIVEN IMAGING'S PILLCAM SB AS FIRST LINE TOOL FOR DETECTING SMALL BOWEL CROHN'S DISEASE YIELDS SAVINGS TO PAYORS
GIVEN IMAGING'S PILLCAM SB AS FIRST LINE TOOL FOR DETECTING SMALL BOWEL CROHN'S DISEASE YIELDS SAVINGS TO PAYORS
Given Imaging, the global leader in capsule endoscopy, has announced that an economic analysis conducted by researchers at Thomas Jefferson University concludes that PillCam SB video capsule endoscopy is less costly from a payor perspective as a first line procedure for detecting small bowel Crohn's disease than traditional diagnostic procedures. The study's authors estimate a $291 cost savings using the PillCam SB compared to the colonoscopy/SBFT combination per patient with suspected small bowel Crohn's disease.
ArriveNet (http://press.arrivenet.com/bus/article.php/558980.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
18Jul
-
21Oct